G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

G&E Herbal Biotechnology Revenue

G&E Herbal Biotechnology had revenue of 34.44M TWD in the quarter ending June 30, 2026, a decrease of -56.97%. This brings the company's revenue in the last twelve months to 215.61M, down -26.73% year-over-year. In the year 2025, G&E Herbal Biotechnology had annual revenue of 309.13M with 24.13% growth.

• Revenue (ttm): 215.61M
• Revenue Growth: -26.73%
• P/S Ratio: 8.60
• Revenue / Employee: 5.01M
• Employees: 43
• Market Cap: 1.85B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	309.13M	60.10M	24.13%
Dec 31, 2024	249.03M	67.59M	37.25%
Dec 31, 2023	181.44M	116.84M	180.84%
Dec 31, 2022	64.61M	40.04M	162.94%
Dec 31, 2021	24.57M	-3.66M	-12.96%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error